跳至主要内容
临床试验/CTRI/2024/04/066217
CTRI/2024/04/066217招募中3 期

Therapeutic Drug Monitoring (TDM) with different tolerable doses of memantine for cognitive function preservation in Indian patients with brain metastasis treated with radiation. - NI

Amrita School of Pharmacy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • (a) patients who are on the Memantine arm of CTRI/2022/01/039599 Trial
  • (b) Patients who are willing to participate in the study, and provide informed consent

排除标准

  • (a) Patients who are on the placebo Arm of CTRI/2022/01/039599 Trial
  • (b) Patients who are not willing to participate in the study, and provide informed consent

研究者

发起方
Amrita School of Pharmacy

相似试验